SCHEMBL25930717

SCHEMBL25930717

O=c1c2ccccc2c2ccccc2n1Cc1cc2ccccc2c2c1ccc1ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.43
RORA P35398 2/20 0.43
RORC P51449 2/20 0.43
RORB Q92753 2/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 3/20 0.39
CMA1 P23946 1/20 0.36
PARP1 P09874 1/20 0.36
NPC1 O15118 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25930728 0.89 PGR (0.43) PGRRORARORCRORBCYP1A2
SCHEMBL25930690 0.83 ALDH1A1 (0.46) PGRRORARORCRORBALDH1A1
SCHEMBL25930694 0.82 TDP1 (0.49) PGRRORARORCRORBCYP1A2
SCHEMBL25930739 0.81 PGR (0.43) PGRRORARORCRORBCYP1A2
SCHEMBL25930681 0.81 CYP1A2 (0.47) PGRRORARORCRORBCYP1A2
SCHEMBL25930714 0.80 ALDH1A1 (0.43) PGRRORARORCRORBCYP1A2
SCHEMBL25930711 0.79 ALDH1A1 (0.42) PGRRORARORCRORBCYP1A2
SCHEMBL25930738 0.78 CYP1A2 (0.48) PGRRORARORCRORBCYP1A2
SCHEMBL25930733 0.78 ALDH1A1 (0.46) PGRRORARORCRORBALDH1A1
SCHEMBL25930731 0.77 PGR (0.50) PGRRORARORCRORBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713319-B2 Compounds having valerolactam structures MERCK PATENT GMBH (DE) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713319-B2 Compounds having valerolactam structures ACE, CYP3A4, CYP2D6 PGR 818/4885RORA 301/4885RORC 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.